Mankind Pharma shares rise 2.07% in early trade; stock among top gainers on Nifty Midcap 150 The stock's last traded price was Rs 2,631.70, reflecting positive investor sentiment in today's session.

Mankind Pharma shares fall 2.20%; stock among top losers on Nifty Midcap 150 Mankind Pharma's stock is currently trading at Rs 2,637.20, reflecting the day's decline.

As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the first quarter is expected to rise year-on-year to ...

Indian pharma is hoping to cash in. Generic firms, such as Biocon, are already offering weight-loss drugs, such as cheaper ...

Torrent Pharmaceuticals to acquire 46.39% stake in JB Chemicals and Pharmaceuticals, merging to strengthen global presence.

Jefferies has raised its target price on Mankind Pharma Ltd., maintaining a 'buy' rating. The target has been hiked to Rs 3,000 from Rs 2,870, as the pharma firm is set for a recovery following a ...

KKR also confirmed the deal in a separate statement. "We are confident that the combined strengths of our organizations will unlock greater opportunities to enhance healthcare access across our ...

India's pharmaceutical sector faced a 6% decline in the Nifty Pharma index in 2025, while the Nifty 50 index rose 8%. Major firms experienced significant losses, though some companies like Laurus ...

Under the terms of the deal, Torrent will initially acquire an equity stake in JB Pharma from KKR for 119.17 billion rupees. Following this, Torrent will launch a mandatory open offer to acquire ...

HealthDay News — Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to ...

Torrent Pharma to acquire J.B. Chemicals & Pharma for equity valuation of ₹25,689 crore This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, says ...

Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB Pharma from global investment firm KKR at an equity valuation of Rs 25,689 crore on a fully diluted basis ...